Via Surgical Ltd., a leading developer of a deployable suture mesh fixation system for hernia repair, announced today it will introduce its lead product, FasTouch™, at the 1st World Conference on Abdominal Wall Hernia Surgery in Milan, Italy, from April 25 to 29, 2015.
Via Surgical to Exhibit at the 1st World Conference on Abdominal Wall Hernia Surgery in Milan, Italy
April 24, 2015
LEARN MORE
Via Surgical Ltd. Receives FDA Clearance to Commercialize FasTouch
April 4, 2014
LEARN MORE
Via Surgical Ltd., a leading developer of hernia mesh fixation technologies, today announced that it has received FDA 510(k) clearance to commercialize FasTouchTM
Via Surgical Appoints Stephen Blumenreich as the Board of Directors Observer
May 29, 2012
LEARN MORE
Mr. Blumenreich, an investment banker at Raymond James, brings nearly 20 years of experience advising growth-oriented medical device companies and has completed numerous capital raising and M&A transactions in the aesthetics, cardiovascular, diabetes, diagnostics, general surgery, orthopedics, and spine subsectors.
Via Surgical Ltd. Announces the Appointment of two Leading US Surgeons
May 9, 2012
LEARN MORE
AMIRIM, Israel, May 9, 2012 /PRNewswire/ —
Via Surgical Ltd., a leading developer of hernia mesh fixation technologies, announced today that it has appointed Karl A. LeBlanc, MD, MBA, FACS and David B. Earle MD, FACS as Medical Advisors.
Schedule a demo
Click below to schedule a demo or have a sales rep contact you
